Category: <span>Research Updates</span>

Home / Research Updates
Post

Gut bug enzyme turns blood into type-O

Scientists believe they have found a reliable way to transform donor blood into the universal type needed for safe, emergency blood transfusions. The discovery is enzymes from gut bacteria that can efficiently turn type-A human blood into type-O. Type-O blood is special because it can be donated to anyone without the risk of a bad...

Post

New method grows brain cells from stem cells quickly and efficiently

Researchers at Lund University in Sweden have developed a faster method to generate functional brain cells, called astrocytes, from embryonic stem cells. Astrocytes play a significant role in neurodegenerative diseases. The new method reduces the time required to produce the cells from months to two weeks, and the study has been published in Nature Methods. “This means...

Post

Researchers demonstrate safe, non-invasive way to open blood-brain barrier in Alzheimer’s patients

In the first peer-reviewed published report of its kind, University of Toronto researchers have demonstrated that focused ultrasound can be used to safely open the blood-brain barrier (BBB) in patients with Alzheimer’s disease. “We are pioneering exciting potential innovative treatment options for patients,” says Professor Sandra Black. Credit: University of Toronto The study, “Blood-brain barrier opening in...

Post

New antibiotic candidates were inside us all along

With bacteria rapidly evolving resistance to our best antibiotics, scientists are searching high and low for new ones. In recent years promising drug candidates have turned up in some unexpected places, like rattlesnake venom, platypus milk, and tobacco flowers – and now, already inside the human body. Researchers from MIT and the University of Naples Federico II have found that a potent peptide...

Post

T-Cell Biomarker Predicts Response to CAR T-Cell Therapy in Patients With CLL

Chimeric antigen receptor (CAR) T-cell therapy has been hailed as one of the great advances in oncology care, but not all patients will respond. This is particularly the case with relapsed/refractory chronic lymphocytic leukemia (CLL), where durable antitumor complete responses have been observed in only 26% of patients,  in contrast to the greater than 90%...

Post

Artificial Retinas Made Of This Ultra-Thin Super Material Could Help Millions See Again

TRULY SUPER. There’s a reason researchers call graphene a “super material.” Even though it’s just a single layer of carbon atoms thick, it’s super strong, super flexible, and super light. It also conducts electricity and is biodegradable. Now an international team of researchers has found a way to use the super material: to create artificial retinas. They presented their work Monday...

Post

Combination immunotherapy shrinks melanoma brain metastases

Combination immunotherapy shrank melanoma that has spread to the brain in more than half of the patients in a clinical trial reported in the New England Journal of Medicine led by an investigator at The University of Texas MD Anderson Cancer Center. Hussein Tawbi, M.D., Ph.D. Credit: MD Anderson Cancer Center Of 94 patients in the single-arm study combining...

Post

Found: A destructive mechanism that blocks the brain from knowing when to stop eating

An international team of researchers has uncovered a destructive mechanism at the molecular level that causes a well-known phenomenon associated with obesity, called leptin resistance. Mice fed a high-fat diet produce an enzyme named MMP-2 that clips receptors for the hormone leptin from the surface of neuronal cells in the hypothalamus. This blocks leptin from binding to...